GAGökçe Güllü Amuran

Gökçe Güllü Amuran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gökçe Güllü Amuran has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Leukocyte Telomere Length as a Marker for Differentiating Carcinoma in Situ of the Bladder from Non-Carcinoma In Situ Bladder Tumors

    by G. Güllü Amuran, I. Peker Eyüboğlu, B. Polat, Y. E. Genç, H. B. Akay, H. K. Çam, M. Akkiprik

    We aimed to assess whether leukocyte telomere length could serve as a non-invasive biomarker for carcinoma in situ (CIS) of the bladder. Genomic DNA was isolated from peripheral whole blood samples and telomere length was therefore considered to reflect leukocyte telomere length. 37 bladder cancer patients and 37 age-matched healthy controls were enrolled to this study. Relative telomere length was measured using quantitative PCR, and associations with clinical outcomes were evaluated. Bladder cancer patients had significantly shorter telomeres than both age-matched (p = 0.0006) and unmatched controls (p = 0.0028). Carcinoma in situ cases exhibited the shortest telomeres, with levels significantly lower than both controls and non-CIS bladder cancer cases (p < 0.0001 and p = 0.0003, respectively). ROC analysis showed strong discriminatory ability for identifying CIS (AUC = 0.848, p < 0.0001; CI: 0.692–0.944). Importantly, no patient with long telomeres experienced recurrence, while shorter telomeres were associated with higher recurrence risk. These findings indicate that peripheral blood telomere length may serve as both a diagnostic and prognostic biomarker in bladder cancer, particularly for CIS. Larger independent cohorts are required to validate its clinical utility.

  • Open Access

    Locked nucleic acid (LNA) based PCR approach for the diagnosis and screening of spinal muscular atrophy

    by Gökçe Güllü Amuran, Büşra Polat, Dilşad Türkdoğan, Olcay Ünver, Mustafa Akkiprik

    Background and objectives: Spinal muscular atrophy (SMA) is an autosomal recessive disorder most often caused by homozygous deletion of exon 7 in the SMN1 gene. Current guidelines recommend initial testing of SMN1 exon 7, with additional analyses if no deletions are found. Commercial kits are typically probe-based; however, LNA (locked nucleic acid)-modified primers provide high sensitivity and specificity at lower cost. We aimed to develop an LNA-based assay for the diagnosis and screening of SMA. Methods: Peripheral blood samples (2 mL) were collected from 31 patients diagnosed with SMA, 37 confirmed healthy controls, and 47 carrier parents between September and December 2021. 3′ LNA-modified primers were designed for the SMN1 , SMN2 , and β-actin genes. For each PCR reaction, 20 ng of template DNA was used in a final volume of 20 µL. Products were validated by Sanger sequencing, and ΔCt values were compared with multiplex ligation-dependent probe amplification (MLPA). Results: The LNA primers for SMN1 , SMN2 , and β-actin were designed and optimised to amplify efficiently under uniform polymerase chain reaction (PCR) conditions. PCR results and ΔCt values were fully concordant with MLPA results. Interpretation and conclusions: Using only LNA-modified primers, we accurately detected SMN1 and SMN2 presence, absence, and copy numbers, without probes. This assay reliably identified both SMA patients and carriers, supporting its potential for diagnostic and screening purposes.

  • NOS1AP: a potential subtype-specific dual role as a tumor suppressor and oncogene in breast cancer subtypes

    by Büşra Polat, Gökçe Güllü Amuran, İrEm Peker Eyüboğlu, Mustafa Ümit Uğurlu, Handan Kaya, Mustafa Akkiprik

    Background NOS1AP/CAPON has been associated with neurological and cardiovascular diseases, but it has recently gained significant attention in cancer research. A limited number of studies conducted on breast cancer (BC) suggest that NOS1AP may possess both tumor suppressive and oncogenic potential. Methods and results This study is the first to investigate the relationship between NOS1AP and EMT (Epithelial-Mesenchymal Transition) in BC tissues and within distinct BC subtypes. Additionally, it provides a pioneering analysis of NOS1AP associations with Hippo pathway components across BC subtypes. The expression levels of NOS1AP, Hippo pathway genes, and EMT markers in primary tissues from different BC subtypes were analyzed using RT-PCR. While NOS1AP expression was reduced in basal BC tissues compared to normal adjacent tissues (NAT), in luminal B BC tissues, only NOS1AP and CDH1 expression showed a significant increase (p < 0.05). Correlation analyses suggest a potential association between NOS1AP, EMT markers, and components of the Hippo pathway. Bioinformatics analysis of overall survival (OS) curves revealed that high NOS1AP expression is associated with prolonged OS, irrespective of BC subtype. Conclusions These findings suggest that NOS1AP may play a dual role in a subtype-specific manner, potentially serving as a subtype-specific biomarker.


  • Open Access

    A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate

    by Gökçe Güllü Amuran, Büşra Polat, Abdülkadir Kahraman, Mustafa Akkiprik

    Although DNA extraction is a crucial step before polymerase chain reaction (PCR), attempts to perform PCR without DNA isolation have been ongoing since the 1990s. While partial success has been achieved with direct conventional PCR, the DNA isolation step has remained indispensable for real-time PCR. Here, we developed a method that does not require complete DNA isolation by lysing EDTA-treated whole blood samples through the application of osmotic pressure and heat, followed by centrifugation to get a clear lysate. Blood samples were mixed with distilled water, incubated at 95 °C for 20 min before centrifugation at 14,000 rpm for 5 min. The resulting lysates were used as templates for real-time PCR. Real-time PCRs were performed under identical conditions with lysates and DNA samples using 9 different primer sets. Target genes were successfully amplified using 1:10 and 1:5 diluted blood lysates both at 60 °C and 61 °C. The PCR efficiency for ACTB and PIK3CA differed by 20% and 14%, respectively, between the DNA samples and blood lysates. We successfully amplified all selected genes using “GG-RT PCR”, greater temperature, greater speed method, without the need for additional enzymes or buffers. GG-RT PCR presents a cost effective option for applications such as SNP analysis and deletion detection if appropriate primer designs are made.


  • Open Access

    Apocynin exhibits an ameliorative effect on endothelial dysfunction/ atherosclerosis-related factors in high-fat diet-induced obesity in rats

    by Nurdan Bülbül Aycı, Büşra Ertaş, Rumeysa Keles Kaya, Sevgi Kocyigit Sevinc, Gökçe Güllü Amuran, Feriha Ercan, Göksel Şener, Oya Orun, Mustafa Akkiprik, Sule Cetinel

    Objective: The aim of this study was to reveal the effect of apocynin (APO) on the factors involved in obesity-related endothelial dysfunction (ED) and atherosclerosis (AS). Materials and Methods: Male Wistar albino rats were divided into control (CNT), high-fat diet (HFD) and HFD+APO groups. HFD and HFD+APO groups were fed HFD for sixteen weeks. APO (25 mg/kg) was administered to the HFD+APO group for the last four weeks. The effects of APO on: AS-related metabolic parameters (triglyceride, total cholesterol, high-density lipoprotein-cholesterol, insulin and leptin), oxidative stress (OS), [ malondialdehyde, glutathione, nicotinamide adenine dinucleotide phosphate (NADPH)- oxidase-2, oxidised-low-density lipoprotein (ox-LDL) and 8-hydroxy-2-deoxyguanosine], low-density lipoprotein and ox-LDL uptake potential (activin receptor-like kinase-1 and lectin-like oxidized low-density lipoprotein receptor-1, respectively), tissue inflammation (myeloperoxidase, monocyte-chemoattractant-protein-1, tumor necrosis factor-alpha), ED (endothelial-nitric oxide synthase, inducible-nitric oxide synthase, nitric oxide), programmed cell death (terminal deoxynucleotidyl-transferase-dUTP-nick-end labeling, cleaved-poly-ADP-ribose-polymerase, gasdermin-D N-terminal fragment, caspase-1), smooth muscle cell transformation (alpha-smooth muscle actin), histology and ultrastructure of thoracic aorta were evaluated. Results: In obesity, APO had an ameliorative effect on metabolic parameters, OS, inflammation, ED, programmed cell death and ox- LDL uptake potential, but not on foam cell formation and LDL uptake potential. Conclusion: Apocynin may improve ED and AS in obesity by suppressing OS-linked factors involved in the early stage of AS.


  • Open Access

    Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

    by İrEm Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M. Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkiprik

    Introduction: Cancer is a genetic disease that affects people worldwide, and breast cancer is the most common cancer in women. Studies have been conducted on molecular parameters to predict tumor behavior and develop therapeutic strategies. Telomeres, which are at the end of chromosomes, have been studied for their relationship with breast cancer, but more research is needed to understand their role in the disease. Circulating‐free DNA (cfDNA) is DNA that is free in the bloodstream and is considered a promising target for early cancer detection, treatment response monitoring, and prognosis assessment. This study is aimed at comparing cfDNA telomere length of breast cancer patients and healthy individuals and analyzing the impact of neoadjuvant chemotherapy on telomere length in cfDNA.Materials and Methods: Blood samples were collected from 33 breast cancer patients undergoing neoadjuvant chemotherapy before and after treatment. The quantitative PCR method is used to measure the average telomere lengths.Results: This study found that the telomere length of cfDNA in breast cancer patients before and after treatment is significantly shorter than in the control group. Neoadjuvant chemotherapy is found to shorten the cfDNA telomere length, especially in the treatment‐responsive group.Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.


  • Open Access

    Methodological Study on the Evaluation of the Performance of Archived RNA Samples in Terms of Gene Expression Analyze

    by Gökçe Güllü Amuran, Büşra Polat, İrem Peker Eyüboğlu, Tolga Özmen, Handan Kaya, Mustafa Akki̇pri̇k

    Amaç: RNA, DNA'ya göre daha düşük kalımlılığa sahip bir moleküldür. RNA analizine dayalı moleküler biyoloji çalışmalarında sıklıkla özel solüsyonlar veya özel şartlar kullanılmaktadır. Bu çalışmada, ddH2O içerisinde çözülmüş, 10 yıl boyunca -40 °C'de saklanmış RNA örneklerinin gen ekspresyon analizi açısından performansının değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: 40 meme dokusundan RNA izole edildi, cDNA sentezinin ardından, eş zamanlı kantitatif polimeraz zincir reaksiyonu ile beta-aktin geninin ekspresyonu incelendi. Örnekler 10 yıl boyunca -40 °C'de saklandı ve 10 yıl sonra deneyler tekrar edildi. Elde edilen eşik döngü (ct) değerleri arasındaki fark GraphPad Prism istatistik paket programı kullanılarak incelendi. Veriler normal dağılıma uygunluk gösterdiğinden eşleştirilmiş t-testi ile incelendi ve istatistiksel anlamlılık için p<0,05 sınır değeri kullanıldı. Bulgular: Kırk RNA örneğinin tümünde beta-aktin ekspresyonu saptandı. Taze örneklerde elde edilen en düşük ve en yüksek ct değerleri 16,17 ve 26,34 iken, 10 yıl bekletilmiş örneklerde 15,66 ve 26,95'tir. Taze örneklerin ortalama ct değeri 20,20 iken, 10 yıl sonra yapılan deneylerde elde edilen ortalama ct değeri 20,84 olmuştur. İki grup arasında anlamlı fark gözlenmemiştir. Sonuç: Elde edilen sonuçlar RNA örneklerinin 10 yıl boyunca -40 °C'de saklanmasının ekspresyon deneylerinde anlamlı farka neden olmadığını, su içerisinde çözülmüş RNA örneklerinin -40 °C'de saklanarak 10 yıl boyunca kullanılabileceğini göstermiştir. RNA örnekleri 10 yıl sonra yeniden incelenmek üzere arşivlenmiştir.

  • Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy

    by Mustafa Akkiprik, Sinan Koca, M. Ümit Uğurlu, Rüçhan Ekren, İrEm Peker Eyüboğlu, Özkan Alan, Can Erzik, Gökçe Güllü Amuran, Tuğba Akın Telli, M. Bahadır Güllüoğlu, et al.